Communiqués Charles River Laboratories International, Inc. Xetra

Actions

RV6

US1598641074

Recherche biotechnologique et médicale

Communiqués

20/08	Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing	BU
05/08	Charles River: Q2 Earnings Snapshot	AQ
05/08	Charles River Laboratories Announces Second-Quarter 2026 Results	BU
15/07	Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call	BU
13/07	Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches	BU
03/07	Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
18/06	Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise	BU
01/06	Charles River Laboratories to Present at William Blair and Jefferies Conferences	BU
13/05	Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions	BU
11/05	Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow	BU
08/05	Charles River Laboratories International : Quarterly Report for Quarter Ending March 28, 2026 (Form 10-Q)	PU
07/05	Charles River Laboratories International : Q1 2026 Earnings Presentation	PU
07/05	Charles River: Q1 Earnings Snapshot	AQ
07/05	Charles River Laboratories Announces First-Quarter 2026 Results	BU
30/04	Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities	BU
21/04	Charles River Highlights Effectiveness of VCGs in Toxicology	BU
16/04	Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call	BU
09/04	Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association	BU
06/04	NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX	PR
02/03	Charles River Laboratories to Present at TD Cowen and Barclays Conferences	BU
25/02	Charles River Laboratories Provides Update on Planned Divestitures	BU
18/02	Charles River Laboratories International : Q4 2025 Earnings Presentation	PU
18/02	Charles River: Q4 Earnings Snapshot	AQ
18/02	Charles River Laboratories Announces Executive Appointments	BU
18/02	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance	BU